Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Pivot Pharmaceuticals Inc (PVOTF)

Pivot Pharmaceuticals Inc (PVOTF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 8,571
  • Shares Outstanding, K 171,414
  • Annual Sales, $ 0 K
  • Annual Income, $ -7,020 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.06
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 05/01/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0301 +66.11%
on 03/23/20
0.1476 -66.12%
on 03/05/20
-0.0100 (-16.67%)
since 02/27/20
3-Month
0.0301 +66.11%
on 03/23/20
0.1714 -70.83%
on 01/08/20
-0.0550 (-52.38%)
since 12/27/19
52-Week
0.0160 +212.50%
on 03/28/19
0.5400 -90.74%
on 05/14/19
-0.1009 (-66.87%)
since 03/27/19

Most Recent Stories

More News
BetterLife Pharma Acquires Swiss Based Solmic AG with Unique Global Patent for Production of New Generation CBD based Biopharmaceuticals

VANCOUVER , Feb. 3, 2020 /PRNewswire/ - BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB: PVOTF / FRA: NPAT) today announced the acquisition of Swiss based Solmic AG with...

BETR : 12.00 (unch)
PVOTF : 0.0544 (+8.80%)
BetterLife Pharma strengthens Board of Directors and Management

The Company prepares for its upcoming launch of its branded product line in the US

BETR : 12.00 (unch)
PVOTF : 0.0544 (+8.80%)
BetterLife Pharma files site evidence package with Health Canada

VANCOUVER , Jan. 6, 2020 /PRNewswire/ - BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB: PVOTF / FRA: NPAT) today announced that it has submitted its site evidence package...

BETR : 12.00 (unch)
PVOTF : 0.0544 (+8.80%)
Pivot Pharmaceuticals re-brands as BetterLife Pharma Inc

Pivot Pharmaceuticals Inc. today announced its corporate name change to BetterLife Pharma Inc. The Company will change its ticker symbol to BETR. taking effect immediately. BetterLife is committed to becoming...

PVOTF : 0.0544 (+8.80%)
Pivot Pharmaceuticals re-brands as BetterLife Pharma Inc

VANCOUVER , Dec. 5, 2019 /PRNewswire/ - Pivot Pharmaceuticals Inc. today announced its corporate name change to BetterLife Pharma Inc. The Company will change its ticker symbol to BETR. taking effect...

PVOTF : 0.0544 (+8.80%)
BETR : 12.00 (unch)
Pivot Pharma Launches Canadian Cannabis and Nutraceutical Manufacturing Facility

Health Canada licensing documentation in preparation; production to start in next 90 days

CCAN : 0.0150 (+15.38%)
PVOTF : 0.0544 (+8.80%)
Pivot Pharma Launches Canadian Cannabis and Nutraceutical Manufacturing Facility

Health Canada licensing documentation in preparation; production to start in next 90 days

PVOTF : 0.0544 (+8.80%)
Pivot Pharma enters US CBD market with its proprietary CBD product line

Pivot Pharmaceuticals Inc. (CSE: PVOT/ OTCQB: PVOTF/ FRA: NPAT) has entered into a contract manufacturing and supply agreement with F&B Cosmetics to manufacture Pivot's differentiated portfolio of CBD...

PVOTF : 0.0544 (+8.80%)
Pivot Pharma enters US CBD market with its proprietary CBD product line

VANCOUVER , Oct. 8, 2019 /PRNewswire/ - Pivot Pharmaceuticals Inc. (CSE: PVOT/ OTCQB: PVOTF/ FRA: NPAT) has entered into a contract manufacturing and supply agreement with F&B Cosmetics to manufacture...

PVOTF : 0.0544 (+8.80%)
PIVOT responds to Stockwatch Article on Notice of Claim filed by Aly Ismail

Pivot Pharmaceuticals Inc. (CSE: PVOT /OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company"), is responding to the Stockwatch Article dated September 18, 2019 regarding the claims filed by Aly Ismail/Green...

PVOTF : 0.0544 (+8.80%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade PVOTF with:

Key Turning Points

2nd Resistance Point 0.0767
1st Resistance Point 0.0633
Last Price 0.0544
1st Support Level 0.0433
2nd Support Level 0.0367

See More

52-Week High 0.5400
Fibonacci 61.8% 0.3398
Fibonacci 50% 0.2780
Fibonacci 38.2% 0.2162
Last Price 0.0544
52-Week Low 0.0160

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar